FDA Adverse Event Malfunction Summary report: N

VERSAONE

MDR report key: 9430519 · Received December 6, 2019

Report

Report Number
9612501-2019-02342
Event Type
Malfunction
Date Received
December 6, 2019
Date of Event
October 4, 2019
Report Date
March 31, 2020
Manufacturer
DAVIS & GECK CARIBE LTD
Product Code
GCJ
UDI-DI
10884521546882
PMA / PMN Number
K151548
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

EVALUATION SUMMARY: POST MARKET VIGILANCE (PMV) LED AN EVALUATION OF ONE DEVICE. THE VISUAL INSPECTION OF THE RETURNED PRODUCT NOTED: THAT THE CIRCULAR SEAL, TROCAR AND CANNULA APPEARED INTACT. THE OBTURATOR WAS RECEIVED. THE STOPCOCK WAS INTACT. A FUNCTIONAL EVALUATION FOUND THAT THE DEVICE PASSED AN AIR LEAK TEST. THE ENVELOPE SEAL PASSES HOWEVER THE INSTRUMENT SEAL LEAKS DURING MANUAL MANIPULATION USING AN ENDO PEANUT. THE TROCAR WAS DISASSEMBLED TO MEASURE WELD HEIGHT, THE WELD HEIGHT WAS IN SPEC. (.250 +/- .005). RECORDS FROM EACH MANUFACTURING LOT ARE THOROUGHLY REVIEWED TO ENSURE THAT PRODUCTS ARE RELEASED MEETING ALL QUALITY RELEASE SPECIFICATIONS AT THE TIME OF MANUFACTURE. THE INVESTIGATION CONCLUDED THERE WERE NO ABNORMALITIES THAT WOULD HAVE CAUSED OR CONTRIBUTED TO THE REPORTED CONDITION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE REPORTER, DURING A LAPAROSCOPIC PROCEDURE, SEAL OF THE TROCAR WAS PHYSICALLY DAMAGED AND AN AIR OR GAS LEAK WAS NOTED FROM THE SEAL. THERE WAS A RAPID LOSS OF ABDOMINAL PRESSURE DUE TO THE DEVICE ISSUE. ANOTHER DEVICE WAS USED TO COMPLETE THE CASE. THERE WAS NO PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1215926 VERSAONE LAPAROSCOPE, GENERAL & PLASTIC SURGERY GCJ DAVIS & GECK CARIBE LTD NONB12STF J8F1108X 10884521546882

Patients

Seq Age Sex Outcome Treatment
1 22 YR